Moderna (MRNA) PT Lowered to $122 at JPMorgan
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $150.38 -2.52%
Rating Summary:
7 Buy, 21 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 9 | New: 31
Rating Summary:
7 Buy, 21 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 9 | New: 31
Join SI Premium – FREE
JPMorgan analyst Jessica Fye lowered the price target on Moderna (NASDAQ: MRNA) to $122.00 (from $165.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Argus Upgrades Moderna (MRNA) to Buy
- MongoDB (MDB) PT Raised to $500 at Monness, Crespi, Hardt
- National Health Investors (NHI) PT Lowered to $80 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
